INS and melanoma: Insulin supplementation has been demonstrated to slow tumour progression in mice carrying B16F10 melanoma,27 suggesting that reduced tumour growth seen in our SIRT6 over‐expressing mice could be attributed partly to upregulation of insulin levels in these mice.